Annual EBIT
-$9.97 M
-$28.19 M-154.77%
31 December 2023
Summary:
Ocuphire Pharma annual earnings before interest & taxes is currently -$9.97 million, with the most recent change of -$28.19 million (-154.77%) on 31 December 2023. During the last 3 years, it has risen by +$7.80 million (+43.88%). OCUP annual EBIT is now -154.77% below its all-time high of $18.22 million.OCUP EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$7.53 M
+$802.00 K+9.63%
30 September 2024
Summary:
Ocuphire Pharma quarterly earnings before interest & taxes is currently -$7.53 million, with the most recent change of +$802.00 thousand (+9.63%) on 30 September 2024. Over the past year, it has dropped by -$13.10 million (-235.00%). OCUP quarterly EBIT is now -121.97% below its all-time high of $34.26 million, reached on 31 December 2022.OCUP Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$28.36 M
-$13.10 M-85.86%
30 September 2024
Summary:
Ocuphire Pharma TTM earnings before interest & taxes is currently -$28.36 million, with the most recent change of -$13.10 million (-85.86%) on 30 September 2024. Over the past year, it has dropped by -$56.67 million (-200.17%). OCUP TTM EBIT is now -200.17% below its all-time high of $28.31 million, reached on 30 September 2023.OCUP TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OCUP EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -154.8% | -235.0% | -200.2% |
| 3 y3 years | +43.9% | -77.9% | +55.4% |
| 5 y5 years | - | - | - |
OCUP EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -154.8% | +82.4% | -122.0% | +9.6% | -200.2% | +55.4% |
| 5 y | 5 years | -154.8% | +82.4% | -122.0% | +80.7% | -200.2% | +55.4% |
| alltime | all time | -154.8% | +82.4% | -122.0% | +80.7% | -200.2% | +55.4% |
Ocuphire Pharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$7.53 M(-9.6%) | -$28.36 M(+85.9%) |
| June 2024 | - | -$8.33 M(+8.0%) | -$15.26 M(+23.9%) |
| Mar 2024 | - | -$7.71 M(+60.7%) | -$12.32 M(+14.7%) |
| Dec 2023 | -$9.97 M(-154.8%) | -$4.80 M(-186.0%) | -$10.74 M(-137.9%) |
| Sept 2023 | - | $5.58 M(-203.5%) | $28.31 M(+55.5%) |
| June 2023 | - | -$5.39 M(-12.1%) | $18.20 M(-2.5%) |
| Mar 2023 | - | -$6.13 M(-117.9%) | $18.67 M(+2.5%) |
| Dec 2022 | $18.21 M | $34.26 M(-856.0%) | $18.21 M(-181.5%) |
| Sept 2022 | - | -$4.53 M(-8.0%) | -$22.36 M(+1.4%) |
| June 2022 | - | -$4.92 M(-25.3%) | -$22.05 M(-9.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$6.59 M(+4.4%) | -$24.27 M(-57.2%) |
| Dec 2021 | -$56.69 M(+219.0%) | -$6.31 M(+49.2%) | -$56.69 M(-10.9%) |
| Sept 2021 | - | -$4.23 M(-40.7%) | -$63.63 M(+5.2%) |
| June 2021 | - | -$7.14 M(-81.7%) | -$60.47 M(+11.5%) |
| Mar 2021 | - | -$39.01 M(+194.3%) | -$54.25 M(+205.3%) |
| Dec 2020 | -$17.77 M(+273.4%) | -$13.26 M(+1139.9%) | -$17.77 M(+293.4%) |
| Sept 2020 | - | -$1.07 M(+16.8%) | -$4.52 M(+31.0%) |
| June 2020 | - | -$915.00 K(-63.9%) | -$3.45 M(+36.1%) |
| Mar 2020 | - | -$2.53 M | -$2.53 M |
| Dec 2019 | -$4.76 M | - | - |
FAQ
- What is Ocuphire Pharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Ocuphire Pharma?
- What is Ocuphire Pharma annual EBIT year-on-year change?
- What is Ocuphire Pharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Ocuphire Pharma?
- What is Ocuphire Pharma quarterly EBIT year-on-year change?
- What is Ocuphire Pharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Ocuphire Pharma?
- What is Ocuphire Pharma TTM EBIT year-on-year change?
What is Ocuphire Pharma annual earnings before interest & taxes?
The current annual EBIT of OCUP is -$9.97 M
What is the all time high annual EBIT for Ocuphire Pharma?
Ocuphire Pharma all-time high annual earnings before interest & taxes is $18.22 M
What is Ocuphire Pharma annual EBIT year-on-year change?
Over the past year, OCUP annual earnings before interest & taxes has changed by -$28.19 M (-154.77%)
What is Ocuphire Pharma quarterly earnings before interest & taxes?
The current quarterly EBIT of OCUP is -$7.53 M
What is the all time high quarterly EBIT for Ocuphire Pharma?
Ocuphire Pharma all-time high quarterly earnings before interest & taxes is $34.26 M
What is Ocuphire Pharma quarterly EBIT year-on-year change?
Over the past year, OCUP quarterly earnings before interest & taxes has changed by -$13.10 M (-235.00%)
What is Ocuphire Pharma TTM earnings before interest & taxes?
The current TTM EBIT of OCUP is -$28.36 M
What is the all time high TTM EBIT for Ocuphire Pharma?
Ocuphire Pharma all-time high TTM earnings before interest & taxes is $28.31 M
What is Ocuphire Pharma TTM EBIT year-on-year change?
Over the past year, OCUP TTM earnings before interest & taxes has changed by -$56.67 M (-200.17%)